Merck Sharp + Dohme Corp.

Samantha E Adamson

Peter J Sinclair

Zhijian Lu

XiaoXia Qian

Christopher Francis Thompson

Wanying Sun

Cameron James Smith

Ramzi Farah Sweis

Yi-Heng Chen

Petr Vachal

Guizhen Dong

Hong Li

Debra L Ondeyka

Julianne A Hunt

Kake Zhao

Florida Kallashi

Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compound of Formula I, Ais a substituted phenyl group or indanyl group. Formula (I). 

Cyclic amine substituted oxazolidinone CETP inhibitor

Growing community of inventors

Charlottesville, VA, United States of America

Samantha E Adamson